Creabilis appoints David Roblin CMO
This article was originally published in Scrip
Creabilis, a clinical stage biotech, has appointed Dr David Roblin chief medical officer. Dr Roblin was most recently Pfizer's senior vice-president, head of research and site head for European R&D. He previously chaired the Research Director's Group of EFPIA, and is currently an advisor at NOCRI in the NHS and a non-executive director of Xceleron.